Literature DB >> 11359327

A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA.

A R Naylor1, P D Hayes, S Darke.   

Abstract

BACKGROUND: a number of studies have examined the outcome of complex wound and graft infections, but most include small numbers of patients collected over a prolonged period of time. To date, there is little information on the clinical outcome of infections involving methicillin-resistant Staphylococcus aureus (MRSA).
METHODS: between February 1998 and January 1999, two prospective multi-centre audits were performed in order to examine the current outcomes following (1) complex vascular wound infections and (2) graft infections in Britain and Ireland with particular reference to outcome associated with MRSA infection.
RESULTS: seventy-five complex wound infections (Szylagyi II and III) were reported, with the commonest single organism being MRSA. Type II infections were associated with a 5% risk of death and/or amputation as opposed to 75% in those with a type III infection. Fifty-five graft infections were reported, with the commonest single organism being MRSA. Overall, 30 (55%) died or underwent amputation. MRSA wound and graft infections were associated with a significantly higher risk of amputation and prolonged hospital stay (but not of death) as compared with MRSA negative patients.
CONCLUSIONS: in this audit, MRSA was the commonest single organism cultured in patients with complex wound and graft infections after vascular surgery. This represents a major change in the spectrum of causative organisms relative to other, older published series. MRSA infections contribute towards an increased risk of adverse outcome and prolonged hospital stay. Copyright 2001 Harcourt Publishers Limited.

Entities:  

Mesh:

Year:  2001        PMID: 11359327     DOI: 10.1053/ejvs.2001.1311

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

1.  Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals.

Authors:  S O'Flaherty; R P Ross; W Meaney; G F Fitzgerald; M F Elbreki; A Coffey
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

2.  Contamination and decontamination of Doppler probes.

Authors:  Emma J Whitehead; John F Thompson; David R Lewis
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

3.  Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?

Authors:  Bruce Y Lee; Becky Y Tsui; Rachel R Bailey; Kenneth J Smith; Robert R Muder; G Jonathan Lewis; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

Review 4.  Prevention of infection in arterial reconstruction.

Authors:  A Stewart; P S Eyers; J J Earnshaw
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

5.  Adherence of Staphylococcus aureus to Dyneema Purity® Patches and to Clinically Used Cardiovascular Prostheses.

Authors:  Amir Basir; Paul Gründeman; Frans Moll; Joost van Herwaarden; Gerard Pasterkamp; Reindert Nijland
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

Review 6.  Groin Surgical Site Infection in Vascular Surgery: Systemic Review on Peri-Operative Antibiotic Prophylaxis.

Authors:  Bruno Amato; Rita Compagna; Salvatore De Vivo; Aldo Rocca; Francesca Carbone; Maurizio Gentile; Roberto Cirocchi; Francesco Squizzato; Andrea Spertino; Piero Battocchio
Journal:  Antibiotics (Basel)       Date:  2022-01-20

7.  Risk Factors for Wound Infections after Vascular Surgery: Kuwait Experience.

Authors:  Abdullah A AlFawaz; Ali H Safar; Ali Al-Mukhaizeem; Emad Kamal; Mohammed Alloush; Ebrahim Hanbal
Journal:  Med Princ Pract       Date:  2022-05-19       Impact factor: 2.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.